A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies
Advanced Healthcare Materials · 2026-02 · 15 (6)
DOI: 10.1002/adhm.202503530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 06.11.2025. Verfasst von Kun Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Central South University, Changsha, Hun…. Hauptthemen laut MEDLINE: Ferroptosis, Copper, Mitophagy, Nanocomposites. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Program of FuRong Laboratory, Hunan Provincial Graduate Research and Innovation Projects.
Abstract (Originalsprache)
Metal ion dyshomeostasis represents a therapeutic vulnerability in cancer, yet simultaneous targeting of multiple metal‐dependent death pathways remains challenging. Herein, a pH‐responsive copper‐based metal‐organic framework nanoplatform (Cu‐MOF@DPCPX) is engineered to co‐trigger cuproptosis, ferroptosis, and mitophagy through tumor‐specific copper overload. The system leverages acidic tumor microenvironments for targeted degradation, releasing Cu 2 ⁺. The liberated Cu 2 ⁺ depletes overexpressed glutathione (GSH) to disrupt redox homeostasis and generates toxic Cu⁺ that initiates dual catalytic cycles. 1) Cu⁺ accumulation promotes lipoylated protein aggregation and Fe‐S cluster loss, driving cuproptosis; 2) Cu⁺‐mediated Fenton‐like reactions convert endogenous H 2 O 2 into hydroxyl radicals (·OH) and downregulate GPX4 to induce ferroptosis. Crucially, mitochondrial damage from these pathways activates mitophagy, which releases sequestered copper to establish a self‐amplifying death cascade. In vivo, Cu‐MOF@DPCPX demonstrates potent tumor suppression across multiple tumor models (4T1‐breast, LLC‐lung, PAN02‐pancreatic, GL261‐glioblastoma), while reprogramming immunosuppressive microenvironments via increased CD8⁺ T‐cell infiltration and M1 macrophage polarization. This triple‐pathway activation strategy overcomes monotherapy limitations and establishes a paradigm for metal‐ion‐based multimodal oncotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Central South University, Changsha, Hunan, 410008, China.
- The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University,…
- FuRong Laboratory, Central South University, Changsha, Hunan, 410078, China.
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
- Department of Radiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, 410000, China.
- Xiangya School of Public Health, Central South University, Changsha, Hunan, 410013, China.
ORCID-Profile: Minghua Wu
Förderung
- National Natural Science Foundation of China
- Scientific Research Program of FuRong Laboratory
- Hunan Provincial Graduate Research and Innovation Projects
Zitieren
APA
Deng, K., Gao, W., Wen, Y., Huang, J., Li, X., Yang, X., & Wu, M. (2026). A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies. Advanced Healthcare Materials, 15(6). https://doi.org/10.1002/adhm.202503530
Vancouver
Deng K, Gao W, Wen Y, Huang J, Li X, Yang X, et al. A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies. Advanced Healthcare Materials. 2026;15(6). doi:10.1002/adhm.202503530
BibTeX
@article{Deng2026,
author = {Deng, Kun and Gao, Wei and Wen, Yu and Huang, Jianliang and Li, Xuetong and Yang, Xiaoxin and Wu, Minghua},
title = {A Functional Nanocomposite Tri‐Activates Cuproptosis, Ferroptosis, and Mitophagy Death Pathway to Oppose Malignancies},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/adhm.202503530}
}
EUVIMED